MORGAN STANLEY - NEUROBO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0760.0%0.00%
Q1 2022$076
-22.4%
0.00%
Q4 2021$098
-30.5%
0.00%
Q3 2021$0141
-24.6%
0.00%
Q2 2021$0
-100.0%
187
-72.1%
0.00%
Q1 2021$2,000
-88.2%
670
-79.7%
0.00%
Q4 2020$17,000
+750.0%
3,296
+550.1%
0.00%
Q3 2020$2,000
-83.3%
507
-63.8%
0.00%
Q2 2020$12,000
+50.0%
1,399
+140.4%
0.00%
Q1 2020$8,000
+700.0%
582
+665.8%
0.00%
Q4 2019$1,000760.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Hayden Royal, LLC 20,642$91,0000.05%
JACOBS LEVY EQUITY MANAGEMENT, INC 173,202$762,0000.01%
SG3 Management, LLC 50,000$220,0000.01%
Ameritas Investment Partners, Inc. 378$2,0000.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 9,817$43,0000.00%
UBS Group AG 2,841$13,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 3,926$17,0000.00%
BANK OF AMERICA CORP /DE/ 11,642$51,0000.00%
WELLS FARGO & COMPANY/MN 13,762$61,0000.00%
NORTHERN TRUST CORP 78,993$348,0000.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders